11 September 2002

Contents

On the web

• ‘Natural’ resistance to HIV: is the evidence good enough to design an effective vaccine?

• Insights into HIV-specific CD4+ T cell immunity

• Cytomegalovirus: update

• The switching spiral: a triumph of hope over benefit?

• Peripheral neuropathy

• The push for once-daily HAART: a call for caution

• Enhancing adherence to antiretrovirals: strategies and regimens

• High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia

• HAART and prevention of HIV transmission